論文

査読有り 国際誌
2019年12月

Pure versus hand-assisted retroperitoneoscopic live donor nephrectomy: a retrospective cohort study of 1508 transplants from two centers.

Surgical endoscopy
  • Hiroshi Noguchi
  • ,
  • Yoichi Kakuta
  • ,
  • Masayoshi Okumi
  • ,
  • Kazuya Omoto
  • ,
  • Yasuhiro Okabe
  • ,
  • Hideki Ishida
  • ,
  • Masafumi Nakamura
  • ,
  • Kazunari Tanabe

33
12
開始ページ
4038
終了ページ
4047
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s00464-019-06697-y

BACKGROUND: Although minimally invasive procedures have been established as the standard for a donor nephrectomy, there are many different surgical techniques described in the literature. The aim of this study is to compare the outcomes of kidney transplant procedures using the pure retroperitoneoscopic donor nephrectomy (PRDN) and hand-assisted retroperitoneoscopic donor nephrectomy (HARDN) techniques. METHODS: A retrospective study involving 1508 transplant procedures was conducted; 874 were PRDN procedures; and 634 were HARDN. We reviewed the outcomes of the PRDN and HARDN groups, which were performed at two different centers over an identical time period. RESULTS: Donors in the PRDN group had a longer operation time (P < 0.0001), reduced estimated blood loss (P < 0.0001), less open conversion (P = 0.0002), lower postoperative serum C-reactive protein levels (P < 0.0001), and a shorter postoperative hospital stay (P < 0.0001) than the HARDN group. Recipients in the PRDN group had lower serum creatinine levels at postoperative day 1-6 and the decreased incidence of slow graft function (P = 0.0017) than the HARDN group. The HARDN procedure was an independent risk factor for the incidence of acute rejection (P = 0.0211) and graft loss (P = 0.0193). CONCLUSIONS: Our study suggests that the PRDN procedure is less invasive for donors as it results in reduced blood loss, lower postoperative serum CRP levels, and a shorter postoperative stay than the HARDN procedure. Additionally, PRDN provides a better outcome for recipients as it lowers the incidence of acute rejection and improves graft survival compared to HARDN.

リンク情報
DOI
https://doi.org/10.1007/s00464-019-06697-y
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/30888499
ID情報
  • DOI : 10.1007/s00464-019-06697-y
  • ISSN : 0930-2794
  • PubMed ID : 30888499

エクスポート
BibTeX RIS